Activated prothrombin complex concentrates and recombinant factor VIIa in the bleeding patient: Are they appropriate and safe?

被引：4

作者：

Aledort, LM ^{[1
]}

机构：

[1] CUNY Mt Sinai Sch Med, New York, NY 10029 USA

来源：

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2003年 / 126卷 / 06期

关键词：

D O I：

10.1016/j.jtcvs.2003.06.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：2112 / 2113

页数：2

相关论文

共 5 条

[1] Aledort LM, 2000, THROMB HAEMOSTASIS, V84, P522
[2] Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII
Bui, JD
Despotis, GD
Trulock, EP
Patterson, GA
Goodnough, LT
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 124 (04) : 852 - 854
[3] Safety of factor VIII inhibitor bypass activity (FEIBA®):: 10-year compilation of thrombotic adverse events
Ehrlich, HJ
Henzl, MJ
Gomperts, ED
[J]. HAEMOPHILIA, 2002, 8 (02) : 83 - 90
[4] Key NS, 2002, THROMB HAEMOSTASIS, V88, P60
[5] Schneiderman J, 2002, BLOOD, V100, p696A